Clinical trial

Changes in Body Composition Under Ustekinumab in PsA

NCT03823924

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2019-03-11

PhaseN/A

Study timeline

Study start (actual)2019-03-11Date precision: day

Registry last updated2022-10-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psoriatic Arthritisverified · MONDO: psoriatic arthritis

Interventions

Bone mineral density (BMD)PROCEDURE

Sponsors & collaborators

University Hospital, Lillelead sponsor

Janssen Pharmaceuticalscollaborator

Mapped research locations

LilleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03823924 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.